CJC-1295
(No DAC) + Ipamorelin Blend
$55.00$35.00
Dual-Peptide Formulation for Synergistic GHRH and GHS Research
The CJC-1295 (No DAC) + Ipamorelin Blend is a specialized research formulation that combines a Growth Hormone Releasing Hormone (GHRH) analog with a selective Growth Hormone Secretagogue (GHS). This blend is designed for controlled laboratory environments to investigate the synchronized modulation of endocrine pathways.
By combining CJC-1295 No DAC (which activates GHRH receptors) with Ipamorelin (a selective GHSR1a agonist), researchers can analyze coordinated peptide signaling and growth hormone pulsatility in vitro.
Core Research Highlights
In preclinical and in vitro environments, this blend is utilized to explore:
Synchronized GH-Releasing Pathways: Researchers study the combined effects of GHRH and ghrelin/GHSR1a receptor activation on growth hormone release kinetics.
Intracellular Signaling Cascades: It serves as a model for mapping downstream signaling pathways involved in pituitary hormone secretion.
Peptide–Receptor Interactions: The blend allows for the study of receptor-specific interactions and the potential for synergistic biological responses.
Pulsatile Secretion Modeling: Because CJC-1295 No DAC provides short-duration activation, it is frequently used to simulate natural, pulsatile endocrine dynamics.
Technical Specifications
This dual-peptide formulation consists of the following technical properties:
Component | Technical Details |
CJC-1295 No DAC | Modified Growth Hormone Releasing Factor (1-29) |
Ipamorelin | Selective Ghrelin/GHSR1a Receptor Agonist |
Combined Purity | ≥ 98% (Batch-tested and third-party verified) |
Form | White to off-white lyophilized powder |
CJC-1295 Sequence | Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH₂ |
Ipamorelin Sequence | Aib-His-D-2-Nal-D-Phe-Lys-NH₂ |
Preparation and Handling
The blend is provided in lyophilized (freeze-dried) form to ensure the stability of both peptide sequences within the same vial.
Reconstitution: This product requires Bacteriostatic Water for reconstitution prior to laboratory use.
Handling Protocol: Diluent should be added slowly to avoid mechanical stress, which can degrade the fragile peptide chains.
Required Supplies: Standard research equipment, including sterile syringes, needles, and alcohol prep pads, is necessary for proper handling.
Storage and Safety Guidelines
Strict environmental controls are necessary to maintain the integrity of the dual-peptide formulation:
Lyophilized (Dry) Storage: Store in a cool, dry environment. Refrigeration at 36°F to 46°F (2°C to 8°C) is recommended for extended stability.
Safety Warning: This product is intended for in-vitro laboratory research only. It is not approved for human or animal consumption, nor for use in clinical trials, diagnostics, or therapeutic applications.